Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 5
194
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The synergic effects of alpha-lipoic acid supplementation and electrical isotonic contraction on anthropometric measurements and the serum levels of VEGF, NO, sirtuin-1, and PGC1-α in obese people undergoing a weight loss diet

, , , &
Pages 1195-1201 | Received 03 Mar 2020, Accepted 24 Apr 2020, Published online: 14 May 2020

References

  • Ansar, H., et al., 2011. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi medical journal, 32 (6), 584–588.
  • Carbonelli, M.G., et al., 2010. α-Lipoic acid supplementation: a tool for obesity therapy? Current pharmaceutical design, 16 (7), 840–846.
  • Chen, W.L., et al., 2012. α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase. Diabetologia, 55 (6), 1824–1835.
  • Chitra, J., et al., 2017. Effect of IFT, HMP V/S faradic current on abdominal fat in centrally obese subjects: a randomised clinical trial. IJAR, 3 (12), 377–381.
  • Dworacka, M., et al., 2015. Alpha-lipoic acid modifies circulating angiogenic factors in patients with type 2 diabetes mellitus. Diabetes research and clinical practice, 107 (2), 273–279.
  • Fernández-Galilea, M., et al., 2013. Antiobesity effects of a-lipoic acid supplementation. Clinical Lipidology, 8 (3), 371–383.
  • Fernández-Galilea, M., et al., 2014. α‐lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects. Obesity, 22 (10), 2210–2215.
  • Fernández-Galilea, M., et al., 2015. α-Lipoic acid treatment increases mitochondrial biogenesis and promotes beige adipose features in subcutaneous adipocytes from overweight/obese subjects. Biochimica et biophysica acta (BBA) – molecular and cell biology of lipids, 1851 (3), 273–281.
  • Gargari, B.P., et al., 2015. Effects of alpha-lipoic acid supplementation on clinical status and anthropometric indices in women with rheumatoid arthritis. Current topics in nutraceutical research, 13 (1), 33–41.
  • Gholamalizadeh, M., et al., 2018. Influence of fat mass-and obesity-associated genotype, body mass index, and dietary intake on effects of iroquois-related homeobox 3 gene on body weight. Chinese medical journal, 131 (17), 2113–2112.
  • Henriksen, E.J., et al., 1997. Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life sciences, 61 (8), 805–812.
  • Hill, J.O., et al., 2003. Obesity and the environment: where do we go from here? Science, 299 (5608), 853–855.
  • Holdsworth, M., et al., 2013. Developing national obesity policy in middle-income countries: a case study from North Africa. Health policy and planning, 28 (8), 858–870.
  • Huerta, A.E., et al., 2015. Effects of α‐lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity, 23 (2), 313–321.
  • Kalantari, N., et al., 2016. The association between dairy intake, simple sugars and body mass index with expression and extent of anger in female students. Iranian journal of psychiatry, 11 (1), 43–50.
  • Kalantari, N., et al., 2017. Indicator for success of obesity reduction programs in adolescents: body composition or body mass index? Evaluating a school-based health promotion project after 12 weeks of intervention. International journal of preventive medicine, 8, 73.
  • Kalantari, N., et al., 2018. A haplotype of three SNPs in FTO had a strong association with body composition and BMI in Iranian male adolescents. PLoS One, 13 (4), e0195589.
  • Kan, E., et al., 2017. Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes. International ophthalmology, 37 (6), 1269–1278.
  • Kim, E., et al., 2008. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. Journal of clinical psychopharmacology, 28 (2), 138–146.
  • Kim, M.S., et al., 2004. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nature medicine, 10 (7), 727–733.
  • Koh, E.H., et al., 2011. Effects of alpha-lipoic acid on body weight in obese subjects. The American journal of medicine, 124 (1), 85.e1–85.e8.
  • Kucukgoncu, S., et al., 2017. Alpha‐lipoic acid (ALA) as a supplementation for weight loss: results from a meta‐analysis of randomized controlled trials. Obesity reviews : an official journal of the International Association for the Study of Obesity, 18 (5), 594–601.
  • Lee, S.R., et al., 2006. The effect of alpha lipoic acid (Thioctacid HR®) on endothelial function in diabetic and hypertensive patients. Korean circulation journal, 36 (8), 559–564.
  • Manco, M. and Dallapiccola, B., 2012. Genetics of pediatric obesity. Pediatrics, 130 (1), 123–133.
  • Manning, P.J., et al., 2013. The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome. Nutrition, metabolism, and cardiovascular diseases : NMCD, 23 (6), 543–549.
  • McNeilly, A.M., et al., 2011. Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids in health and disease, 10 (1), 217.
  • Ng, M., et al., 2014. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The lancet, 384 (9945), 766–781.
  • Prieto-Hontoria, P.L., et al., 2009. Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. Journal of physiology and biochemistry, 65 (1), 43–50.
  • Razavi, T.A., et al., 2012. Comparing the effect of faradic and aerobic exercise on circumference, % fat and endurance of abdomen in non-athlete women. World, 6 (4), 367–371.
  • Ruhnau, K.J., et al., 1999. Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy. Diabetic medicine: a journal of the British Diabetic Association, 16 (12), 1040–1043.
  • Shay, K.P., et al., 2009. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochimica et biophysica acta (BBA) - general subjects, 1790 (10), 1149–1160.
  • Shidfar, F., et al., 2018. The effects of extra virgin olive oil on alanine aminotransferase, aspartate aminotransferase, and ultrasonographic indices of hepatic steatosis in nonalcoholic fatty liver disease patients undergoing low calorie diet. Canadian journal of gastroenterology and hepatology, 2018, 1–7.,
  • Stark, R., Ashley, S.E., and Andrews, Z.B., 2013. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Molecular and cellular endocrinology, 366 (2), 215–223.
  • Tromba, L., et al., 2019. Effect of alpha-lipoic acid supplementation on endothelial function and cardiovascular risk factors in overweight/obese youths: a double-blind, placebo-controlled randomized trial. Nutrients, 11, 375.
  • Udupa, A.S., et al., 2012. Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus. Journal of clinical and diagnostic research: JCDR, 6 (9), 1469–1473.
  • Valdecantos, M.P., et al., 2012. Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3. Obesity, 20 (10), 1974–1983.
  • Vinciguerra, M., et al., 2010. SirT1 in muscle physiology and disease: lessons from mouse models. Disease models and mechanisms, 3 (5-6), 298–303.
  • Yang, Y., et al., 2014. Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1/LKB1/AMPK pathway. The journal of nutritional biochemistry, 25 (11), 1207–1217.
  • Ziegler, D., et al., 2006. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes care, 29 (11), 2365–2370.
  • Ziegler, D., et al., 2011. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes care, 34 (9), 2054–2060.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.